The slow cell death response when screening chemotherapeutic agents

被引:14
作者
Blois, Joseph [1 ]
Smith, Adam [1 ]
Josephson, Lee [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Translat Nucl Med & Mol Imaging CTNMI, Charlestown, MA 02129 USA
关键词
Apoptosis; Annexin V; Chemotherapy; Cell death; Screening; Cytotoxicity; IN-VITRO; ASSAY; APOPTOSIS; CISPLATIN; NECROSIS; PROTEIN; INJURY; NCI60;
D O I
10.1007/s00280-010-1549-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To examine the correlation between cell death and a common surrogate of death used in screening assays, we compared cell death responses to those obtained with the sulforhodamine B (SRB) cell protein-based "cytotoxicity" assay. With the SRB assay, the Hill equation was used to obtain an IC50 and final cell mass, or cell mass present at infinite agent concentrations, with eight adherent cell lines and four agents (32 agent/cell combinations). Cells were treated with high agent concentrations (well above the SRB IC50) and the death response determined as the time-dependent decrease in cells failing to bind both annexin V and vital fluorochromes by flow cytometry. Death kinetics were categorized as fast (5/32) (similar to the reference nonadherent Jurkat line), slow (17/32), or none (10/32), despite positive responses in the SRB assay in all cases. With slow cell death, a single exposure to a chemotherapeutic agent caused a slow, progressive increase in dead (necrotic) and dying (apoptotic) cells for at least 72 h. Cell death (defined by annexin and/or fluorochrome binding) did not correlate with the standard SRB "cytotoxicity" assay. With the slow cell death response, a single exposure to an agent caused a slow conversion from vital to apoptotic and necrotic cells over at least 72 h (the longest time point examined). Here, increasing the time of exposure to agent concentrations modestly above the SRB IC50 provides a method of maximizing cell kill. If tumors respond similarly, sustained low doses of chemotherapeutic agents, rather than a log-kill, maximum tolerated dose strategy may be an optimal strategy of maximizing tumor cell death.
引用
收藏
页码:795 / 803
页数:9
相关论文
共 21 条
[1]  
ANDREOTTI PE, 1995, CANCER RES, V55, P5276
[2]  
Blankenberg Francis G, 2009, Proc Am Thorac Soc, V6, P469, DOI 10.1513/pats.200901-001AW
[3]   From the Gla domain to a novel small-molecule detector of apoptosis [J].
Cohen, Avi ;
Shirvan, Anat ;
Levin, Galit ;
Grimberg, Hagit ;
Reshef, Ayelet ;
Ziv, Ilan .
CELL RESEARCH, 2009, 19 (05) :625-637
[4]   Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines [J].
Denoyer, D ;
Perek, N ;
Le Jeune, N ;
Cornillon, J ;
Dubois, F .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (07) :820-827
[5]   Necrosis avidity of 99mTc(CO)3-Labeled pamoic acid derivatives:: Synthesis and preliminary biological evaluation in animal models of necrosis [J].
Fonge, Humphrey ;
Chitneni, Satish K. ;
Lixin, Jin ;
Vunckx, Kathleen ;
Prinsen, Kristof ;
Nuyts, Johan ;
Mortelmans, Luc ;
Bormans, Guy ;
Ni, Yicheng ;
Verbruggen, Alfons .
BIOCONJUGATE CHEMISTRY, 2007, 18 (06) :1924-1934
[6]  
Fricker SP, 1996, ANTICANCER RES, V16, P3755
[7]   Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes [J].
Galluzzi, L. ;
Aaronson, S. A. ;
Abrams, J. ;
Alnemri, E. S. ;
Andrews, D. W. ;
Baehrecke, E. H. ;
Bazan, N. G. ;
Blagosklonny, M. V. ;
Blomgren, K. ;
Borner, C. ;
Bredesen, D. E. ;
Brenner, C. ;
Castedo, M. ;
Cidlowski, J. A. ;
Ciechanover, A. ;
Cohen, G. M. ;
De Laurenzi, V. ;
De Maria, R. ;
Deshmukh, M. ;
Dynlacht, B. D. ;
El-Deiry, W. S. ;
Flavell, R. A. ;
Fulda, S. ;
Garrido, C. ;
Golstein, P. ;
Gougeon, M-L ;
Green, D. R. ;
Gronemeyer, H. ;
Hajnoczky, G. ;
Hardwick, J. M. ;
Hengartner, M. O. ;
Ichijo, H. ;
Jaattela, M. ;
Kepp, O. ;
Kimchi, A. ;
Klionsky, D. J. ;
Knight, R. A. ;
Kornbluth, S. ;
Kumar, S. ;
Levine, B. ;
Lipton, S. A. ;
Lugli, E. ;
Madeo, F. ;
Malorni, W. ;
Marine, J-C W. ;
Martin, S. J. ;
Medema, J. P. ;
Mehlen, P. ;
Melino, G. ;
Moll, U. M. .
CELL DEATH AND DIFFERENTIATION, 2009, 16 (08) :1093-1107
[8]   A DNA-binding Gd chelate for the detection of cell death by MRI [J].
Garanger, Elisabeth ;
Hilderbrand, Scott A. ;
Blois, Joseph T. ;
Sosnovik, David E. ;
Weissleder, Ralph ;
Josephson, Lee .
CHEMICAL COMMUNICATIONS, 2009, (29) :4444-4446
[9]   Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model [J].
Guchelaar, HJ ;
Vermes, I ;
Koopmans, RP ;
Reutelingsperger, CPM ;
Haanen, C .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (01) :77-83
[10]   A NOVEL INVITRO CHEMOSENSITIVITY TEST USING MATERIALS COLLECTED BY ENDOSCOPIC BIOPSY [J].
HIRAI, T ;
KAWANO, K ;
HIRABAYASHI, N ;
NISHIYAMA, M ;
YAMASHITA, Y ;
MUKAIDA, H ;
IWATA, T ;
TOGE, T .
ANTI-CANCER DRUGS, 1991, 2 (03) :269-274